Moderna, Inc. vs Opendoor Technologies Inc — how do they compare? Moderna, Inc. trades at $59.68 (market cap $23.60B), while Opendoor Technologies Inc trades at $4.48 (market cap $4.29B). The key difference: Moderna, Inc. is far larger — about 5.5× Opendoor Technologies Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, Opendoor Technologies Inc nearer its low. Which is the better fit depends on your goals.
| MRNA | OPEN | |
|---|---|---|
Market Cap | $23.60B | $4.29B |
Sector | Health | Real Estate |
52-Week High | $81.80 | $10.52 |
52-Week Low | $22.36 | $1.84 |
Enterprise Value | $19.70B | $4.63B |
Trailing returns across standard periods
Latest headlines on both assets
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.
Read more on OPEN →